Barclays
IRIX icon

Barclays’s IRIDEX IRIX Stock Holding History

Barclays’s Portfolio IRIX Stock Details IRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-122
Closed -$1K – 4965
2021
Q1 		$1K Buy
+122
New +$702 ﹤0.01% 4594
2017
Q3 		– Sell
-7,775
Closed -$77K – 6931
2017
Q2 		$77K Buy
7,775
+7,731
+17,570% +$76.1K ﹤0.01% 5087
2017
Q1 		$0 Sell
44
-2
-4% -$28 ﹤0.01% 6856
2016
Q4 		$1K Sell
46
-36
-44% -$511 ﹤0.01% 6468
2016
Q3 		$1K Sell
82
-4,227
-98% -$64.2K ﹤0.01% 6400
2016
Q2 		$64K Buy
+4,309
New +$53.7K ﹤0.01% 4699
2015
Q2 		– Sell
-14
Closed – – 7104
2015
Q1 		$0 Buy
+14
New +$136 ﹤0.01% 7161
2014
Q3 		– Sell
-500
Closed -$4K – 7732
2014
Q2 		$4K Buy
+500
New +$4.3K ﹤0.01% 7192
2013
Q4 		– Sell
-200
Closed -$1K – 7601
2013
Q3 		$1K Sell
200
-200
-50% -$1.19K ﹤0.01% 7298
2013
Q2 		$2K Buy
+400
New +$2.15K ﹤0.01% 7528

Other funds holding IRIX

PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's IRIX Position: Q2 2021 in Review

Barclays sold out of IRIDEX (IRIX) in Q2 2021, closing a stake of 122 shares — an estimated $1K sold.

Barclays first reported a position in IRIX in Q2 2013 and held it in 10 quarters. The position peaked at $77K in Q2 2017. 33 funds tracked by Wall St. Rank hold IRIX as of Q2 2021.

  • Barclays reported no remaining IRIDEX position as of Q2 2021 after selling out during the quarter.
  • Barclays sold 122 IRIDEX shares in Q2 2021, an estimated $1K.
  • Barclays first reported a position in IRIDEX in Q2 2013 and held it in 10 quarters.
  • Barclays's IRIDEX position peaked at $77K in Q2 2017.
  • 33 funds tracked by Wall St. Rank held IRIDEX as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.